Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-03

Clinical Trial Update: Collagen Markers in Heart Failure and Preserved Ejection Fraction

View source ↗

Summary

Terminated clinical trial evaluating collagen markers in heart failure with preserved ejection fraction (HFpEF), sponsored by University Hospital, Rouen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Rouen | Conditions: Left-sided Congestive Heart Failure | Status: TERMINATED